{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:12:06Z","timestamp":1777428726228,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903787"],"award-info":[{"award-number":["81903787"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"crossref","award":["YQ2021H002"],"award-info":[{"award-number":["YQ2021H002"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s11418-022-01626-1","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T17:23:32Z","timestamp":1652117012000},"page":"765-773","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Refined-JinQi-JiangTang tablet ameliorates hypertension through activation of FGF21\/FGFR1 axis in fructose-fed rats"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8750-687X","authenticated-orcid":false,"given":"Siming","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangxin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"key":"1626_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature06882","volume":"453","author":"E Holmes","year":"2008","unstructured":"Holmes E, Loo RL, Stamler J et al (2008) Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453:396\u2013400. https:\/\/doi.org\/10.1038\/nature06882","journal-title":"Nature"},{"key":"1626_CR2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev-physiol-031620-123956","volume":"83","author":"WL Xu","year":"2021","unstructured":"Xu WL, Janocha AJ, Erzurum SC (2021) Metabolism in pulmonary hypertension. Annu Rev Physiol 83:551\u2013576. https:\/\/doi.org\/10.1146\/annurev-physiol-031620-123956","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"1626_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11892-010-0155-x","volume":"11","author":"K Chaudhary","year":"2011","unstructured":"Chaudhary K, Buddineni JP, Nistala R et al (2011) Resistant hypertension in the high-risk metabolic patient. Curr Diab Rep 11(1):41\u201346. https:\/\/doi.org\/10.1007\/s11892-010-0155-x","journal-title":"Curr Diab Rep"},{"issue":"6","key":"1626_CR4","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1161\/HYPERTENSIONAHA.120.13896","volume":"75","author":"S Chakraborty","year":"2020","unstructured":"Chakraborty S, Mandal J, Yang T et al (2020) Metabolites and hypertension: insights into hypertension as a metabolic disorder: 2019 harriet dustan award. Hypertension 75(6):1386\u20131396. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.13896","journal-title":"Hypertension"},{"key":"1626_CR5","doi-asserted-by":"publisher","unstructured":"Whelton PK, Carey RM, Aronow WS et al (2018) 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 71(19): e127-e248. Doi: https:\/\/doi.org\/10.1016\/j.jacc.2017.11.006","DOI":"10.1016\/j.jacc.2017.11.006"},{"issue":"9841","key":"1626_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0140-6736(12)60825-3","volume":"380","author":"S Laurent","year":"2012","unstructured":"Laurent S, Schlaich M, Esler M (2012) New drugs, procedures, and devices for hypertension. Lancet 380(9841):591\u2013600. https:\/\/doi.org\/10.1016\/S0140-6736(12)60825-3","journal-title":"Lancet"},{"issue":"2","key":"1626_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40264-014-0250-z","volume":"38","author":"SH Liu","year":"2015","unstructured":"Liu SH, Chuang WC, Lam W et al (2015) Safety surveillance of traditional Chinese medicine: current and future. Drug Saf 38(2):117\u2013128. https:\/\/doi.org\/10.1007\/s40264-014-0250-z","journal-title":"Drug Saf"},{"key":"1626_CR8","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2018.3","volume":"20","author":"JG Wang","year":"2018","unstructured":"Wang JG, Wong YK, Liao FL (2018) What has traditional Chinese medicine delivered for modern medicine. Expert Rev Mol Med 20:e4. https:\/\/doi.org\/10.1017\/erm.2018.3","journal-title":"Expert Rev Mol Med"},{"key":"1626_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2019.02.038","volume":"236","author":"Y Liu","year":"2019","unstructured":"Liu Y, Wang AT, Wen LN et al (2019) A Chinese medicine formula (Jinqi Jiangtang Tablet): A review on its chemical constituents, quality control, pharmacokinetics studies, pharmacological properties and clinical applications. J Ethnopharmacol 236:1\u20138. https:\/\/doi.org\/10.1016\/j.jep.2019.02.038","journal-title":"J Ethnopharmacol"},{"key":"1626_CR10","doi-asserted-by":"publisher","first-page":"1872134","DOI":"10.1155\/2019\/1872134","volume":"2019","author":"Y Cao","year":"2019","unstructured":"Cao Y, Yao GW, Sheng YY et al (2019) JinQi Jiangtang tablet regulates gut microbiota and improve insulin sensitivity in type 2 diabetes mice. J Diabetes Res 2019:1872134. https:\/\/doi.org\/10.1155\/2019\/1872134","journal-title":"J Diabetes Res"},{"issue":"1","key":"1626_CR11","doi-asserted-by":"publisher","first-page":"11190","DOI":"10.1038\/s41598-017-11583-5","volume":"7","author":"H Wang","year":"2017","unstructured":"Wang H, Guo LP, Shang HC et al (2017) JinqiJiangtang tablets for pre-diabetes: a randomized, double-blind and placebo-controlled clinical trial. Sci Rep 7(1):11190. https:\/\/doi.org\/10.1038\/s41598-017-11583-5","journal-title":"Sci Rep"},{"issue":"2","key":"1626_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1161\/01.hyp.0000024267.71656.0d","volume":"40","author":"Y Nishimoto","year":"2002","unstructured":"Nishimoto Y, Tomida T, Matsui H et al (2002) Decrease in renal medullary endothelial nitric oxide synthase of fructose-fed, salt-sensitive hypertensive rats. Hypertension 40(2):190\u2013194. https:\/\/doi.org\/10.1161\/01.hyp.0000024267.71656.0d","journal-title":"Hypertension"},{"issue":"5","key":"1626_CR13","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1097\/HJH.0000000000000551","volume":"33","author":"AV Klein","year":"2015","unstructured":"Klein AV, Kiat H (2015) The mechanisms underlying fructose-induced hypertension: a review. J Hypertens 33(5):912\u2013920. https:\/\/doi.org\/10.1097\/HJH.0000000000000551","journal-title":"J Hypertens"},{"issue":"03","key":"1626_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1875-5364(14)60039-X","volume":"12","author":"S Sun","year":"2014","unstructured":"Sun S, Xie ZS, Liu EH et al (2014) Chemical profiling of Jinqi Jiangtang tablets by HPLC-ESI-Q-TOF\/MS. Chin J Nat Med 12(03):229\u2013240. https:\/\/doi.org\/10.1016\/S1875-5364(14)60039-X","journal-title":"Chin J Nat Med"},{"key":"1626_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jep.2015.02.018","volume":"164","author":"YX Chang","year":"2015","unstructured":"Chang YX, Ge AH, Donnapee S et al (2015) The multi-targets integrated fingerprinting for screening anti-diabetic compounds from a Chinese medicine Jinqi Jiangtang Tablet. J Ethnopharmacol 164:210\u2013222. https:\/\/doi.org\/10.1016\/j.jep.2015.02.018","journal-title":"J Ethnopharmacol"},{"issue":"08","key":"1626_CR16","doi-asserted-by":"publisher","first-page":"e8791","DOI":"10.15252\/emmm.201708791","volume":"10","author":"V Jimenez","year":"2018","unstructured":"Jimenez V, Jambrina C, Casana E et al (2018) FGF21 gene therapy as treatment for obesity and insulin resistance. EMBO Mol Med 10(08):e8791. https:\/\/doi.org\/10.15252\/emmm.201708791","journal-title":"EMBO Mol Med"},{"issue":"6","key":"1626_CR17","doi-asserted-by":"publisher","first-page":"H1029","DOI":"10.1152\/ajpheart.00527.2015","volume":"309","author":"EM Domouzoglou","year":"2015","unstructured":"Domouzoglou EM, Naka KK, Vlahos AP et al (2015) Fibroblast growth factors in cardiovascular disease: the emerging role of FGF21. Am J Physiol Heart Circ Physiol 309(6):H1029\u2013H1038. https:\/\/doi.org\/10.1152\/ajpheart.00527.2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1626_CR18","doi-asserted-by":"publisher","first-page":"29582","DOI":"10.1038\/srep29582","volume":"6","author":"JL He","year":"2016","unstructured":"He JL, Zhao M, Xia JJ et al (2016) FGF21 ameliorates the neurocontrol of blood pressure in the high fructose-drinking rats. Sci Rep 6:29582. https:\/\/doi.org\/10.1038\/srep29582","journal-title":"Sci Rep"},{"issue":"6","key":"1626_CR19","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.cmet.2018.04.002","volume":"27","author":"XB Pan","year":"2018","unstructured":"Pan XB, Shao YH, Wu F et al (2018) FGF21 prevents angiotensin II-induced hypertension and vascular dysfunction by activation of ACE2\/Angiotensin-(1\u20137) Axis in Mice. Cell Metab 27(6):1323-1337.e5. https:\/\/doi.org\/10.1016\/j.cmet.2018.04.002","journal-title":"Cell Metab"},{"key":"1626_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/bs.vh.2016.02.008","volume":"101","author":"DM Kilkenny","year":"2016","unstructured":"Kilkenny DM, Rocheleau JV (2016) The FGF21 receptor signaling complex: Klotho\u03b2, FGFR1c, and other regulatory interactions. Vitam Horm 101:17\u201358. https:\/\/doi.org\/10.1016\/bs.vh.2016.02.008","journal-title":"Vitam Horm"},{"issue":"12","key":"1626_CR21","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/13543776.2019.1688300","volume":"29","author":"G Marseglia","year":"2019","unstructured":"Marseglia G, Lodola A, Mor M et al (2019) Fibroblast growth factor receptor inhibitors: patent review (2015\u20132019). Expert Opin Ther Pat 29(12):965\u2013977. https:\/\/doi.org\/10.1080\/13543776.2019.1688300","journal-title":"Expert Opin Ther Pat"},{"key":"1626_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.expneurol.2019.02.013","volume":"317","author":"LX Ye","year":"2019","unstructured":"Ye LX, Wang X, Cai CC et al (2019) FGF21 promotes functional recovery after hypoxic-ischemic brain injury in neonatal rats by activating the PI3K\/Akt signaling pathway via FGFR1\/\u03b2-klotho. Exp Neurol 317:34\u201350. https:\/\/doi.org\/10.1016\/j.expneurol.2019.02.013","journal-title":"Exp Neurol"},{"key":"1626_CR23","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.biopha.2018.09.143","volume":"108","author":"N Wang","year":"2018","unstructured":"Wang N, Li JY, Li S et al (2018) Fibroblast growth factor 21 regulates foam cells formation and inflammatory response in Ox-LDL-induced THP-1 macrophages. Biomed Pharmacother 108:1825\u20131834. https:\/\/doi.org\/10.1016\/j.biopha.2018.09.143","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1626_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10753-015-0251-9","volume":"39","author":"SM Li","year":"2016","unstructured":"Li SM, Yu YH, Li L et al (2016) Treatment of CIA Mice with FGF21 Down-regulates TH17-IL-17 Axis. Inflammation 39(1):309\u2013319. https:\/\/doi.org\/10.1007\/s10753-015-0251-9","journal-title":"Inflammation"},{"issue":"2","key":"1626_CR25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1172\/JCI67353","volume":"124","author":"B Emanuelli","year":"2014","unstructured":"Emanuelli B, Vienberg SG, Smyth G et al (2014) Interplay between FGF21 and insulin action in the liver regulates metabolism. J Clin Invest 124(2):515\u2013527. https:\/\/doi.org\/10.1172\/JCI67353","journal-title":"J Clin Invest"},{"issue":"3","key":"1626_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s12020-015-0801-9","volume":"52","author":"D Yu","year":"2016","unstructured":"Yu D, Ye XL, Wu Q et al (2016) Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway. Endocrine 52(3):527\u2013540. https:\/\/doi.org\/10.1007\/s12020-015-0801-9","journal-title":"Endocrine"},{"issue":"1","key":"1626_CR27","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jep.2013.11.024","volume":"151","author":"LH Gao","year":"2014","unstructured":"Gao LH, Liu Q, Liu SN et al (2014) A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice. J Ethnopharmacol 151(1):675\u2013685. https:\/\/doi.org\/10.1016\/j.jep.2013.11.024","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"1626_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.apsb.2017.04.010","volume":"7","author":"Q Liu","year":"2017","unstructured":"Liu Q, Liu SN, Gao LH et al (2017) Anti-diabetic effects and mechanisms of action of a Chinese herbal medicine preparation JQ-R in vitro and in diabetic KK Ay mice. Acta Pharm Sin B 7(4):461\u2013469. https:\/\/doi.org\/10.1016\/j.apsb.2017.04.010","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"1626_CR29","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/j.bbrc.2017.12.070","volume":"495","author":"FY Zhou","year":"2018","unstructured":"Zhou FY, My B, Zhnag YQ et al (2018) Berberine-induced activation of AMPK increases hepatic FGF21 expression via NUR77-ScienceDirect. Biochem Biophys Res Commun 495(2):1936\u20131941. https:\/\/doi.org\/10.1016\/j.bbrc.2017.12.070","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1626_CR30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/bph.14079","volume":"175","author":"YX Sun","year":"2018","unstructured":"Sun YX, Xia MF, Yan HM et al (2018) Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21. Br J Pharmacol 175(2):374\u2013387. https:\/\/doi.org\/10.1111\/bph.14079","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1626_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MNH.0b013e3283406f57","volume":"20","author":"CM Ferrario","year":"2011","unstructured":"Ferrario CM (2011) ACE2: more of Ang-(1\u20137) or less AngII. Curr Opin Nephrol Hypertens 20(1):1\u20136. https:\/\/doi.org\/10.1097\/MNH.0b013e3283406f57","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7","key":"1626_CR32","doi-asserted-by":"publisher","first-page":"109128","DOI":"10.1016\/J.CELREP.2021.109128","volume":"35","author":"J Sostre-Col\u00f3n","year":"2021","unstructured":"Sostre-Col\u00f3n J, Uehara K, Garcia WA et al (2021) Hepatic AKT orchestrates adipose tissue thermogenesis via FGF21-dependent and -independent mechanisms. Cell Rep 35(7):109128. https:\/\/doi.org\/10.1016\/J.CELREP.2021.109128","journal-title":"Cell Rep"},{"issue":"27","key":"1626_CR33","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1016\/j.febslet.2008.10.021","volume":"582","author":"Y Izumiya","year":"2008","unstructured":"Izumiya Y, Bina HA, Ouchi N et al (2008) FGF21 is an Akt-regulated myokine. FEBS Lett 582(27):3805\u20133810. https:\/\/doi.org\/10.1016\/j.febslet.2008.10.021","journal-title":"FEBS Lett"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-022-01626-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-022-01626-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-022-01626-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T17:14:03Z","timestamp":1661447643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11418-022-01626-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1626"],"URL":"https:\/\/doi.org\/10.1007\/s11418-022-01626-1","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"value":"1340-3443","type":"print"},{"value":"1861-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,9]]},"assertion":[{"value":"6 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}